Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kwan Loong is a globally recognized consumer healthcare brand specializing in topical analgesic oils and balms designed for the relief of muscle aches, joint pain, and headaches. Founded in the 1930s by Tan Ngak Kok, the brand is currently owned and manufactured by Haw Par Healthcare, a subsidiary of the publicly traded Haw Par Corporation. The company's flagship product, Kwan Loong Medicated Oil, utilizes a specific formulation of menthol, methyl salicylate, and camphor to provide rapid pain relief through topical application. Operating primarily in the over-the-counter (OTC) and traditional medicine markets, Kwan Loong maintains a significant commercial presence across Asia and North America. The brand is often positioned alongside its sister brand, Tiger Balm, as a staple in external pain management. Its manufacturing processes adhere to Good Manufacturing Practice (GMP) standards to ensure product quality and safety for international distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kwan Loong International Company.